ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Electronic Technology

Shimadzu Corp.

Business Summary

Shimadzu Corp. engages in the manufacture and sale of testing, measuring, medical, aircraft and analytical instruments. It operates through the following segments: Analytical Instruments, Medical Systems, Aircraft Equipment, Industrial Machinery & Equipment, and Others. The Analytical Instruments segment handles the general analytical and environmental measurement instruments such as mass spectrometers, chromatographs, spectrophotometers, surface analysis and observation systems, water quality analyzers, and continuous emission monitoring systems. The Medical System segment offers diagnostic systems and services to medical facilities such as fluoroscopy, angiography, radiography, near-infrared imaging, and medical information systems. The Aircraft Equipment segment provides aircraft and ground support equipment which includes flight control, air management, cockpit display systems, aircraft equipment functional testers, and aircraft medical training equipment. The Industrial Machinery & Equipment segment offers advanced-level manufacturing and testing equipment for the industrial field such as turbo molecular pumps, anti-reflective coating systems for solar cells, hydraulic gear pumps, power packages, diffraction gratings, and laser modules. The Others segment handles the leasing and management of real estate, software development, product design, and pavement construction business. The company was founded by Genzo Shimadzu Sr. on March 31, 1875 and is headquartered in Kyoto, Japan.

Financial Highlights

Mar 2020 JPYUSD
Revenue385,443M3,545.09M
Gross Profit152,430M1,401.96M
Operating income41,846M384.87M
Income before tax43,113M396.52M
Net income31,765M292.15M
EBITDA55,258M508.23M
Diluted EPS107.830.99
Dividends Per Share300.27
Total Assets437,618M4,053.70M
Total liabilities134,840M1,249.03M
Total equity302,775M2,804.64M
Operating cash flow39,509M363.38M
Currency in JPYCurrency in USD

Historical Data

 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 342,236M 342,479M 376,530M 391,213M 385,443M
Gross Profit 140,386M 136,409M 149,833M 157,169M 152,430M
Operating income 35,701M 37,090M 42,822M 44,481M 41,846M
Income before tax 34,021M 36,113M 41,775M 44,652M 43,113M
Net income 23,899M 26,473M 29,838M 32,524M 31,765M
EBITDA 45,140M 46,673M 53,460M 56,117M 55,258M
Diluted EPS 81.05 89.79 101.26 110.40 107.83
Dividends Per Share 18 20 24 28 30
Total Assets 349,798M 375,354M 418,548M 437,190M 437,618M
Total liabilities 129,827M 133,722M 150,484M 149,246M 134,840M
Total equity 219,694M 241,332M 267,694M 287,894M 302,775M
Operating cash flow 32,348M 29,608M 41,215M 29,454M 39,509M
 Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Revenue 2,849.96M 3,162.68M 3,397.29M 3,527.78M 3,545.09M
Gross Profit 1,169.06M 1,259.69M 1,351.88M 1,417.28M 1,401.96M
Operating income 297.29M 342.51M 386.36M 401.11M 384.87M
Income before tax 283.30M 333.49M 376.92M 402.65M 396.52M
Net income 199.01M 244.46M 269.21M 293.28M 292.15M
EBITDA 375.90M 431.01M 482.34M 506.03M 508.23M
Diluted EPS 0.67 0.82 0.91 0.99 0.99
Dividends Per Share 0.14 0.18 0.21 0.25 0.27
Total Assets 3,112.22M 3,368.51M 3,935.57M 3,949.85M 4,053.70M
Total liabilities 1,155.09M 1,200.05M 1,414.98M 1,348.38M 1,249.03M
Total equity 1,954.65M 2,165.77M 2,517.10M 2,601.02M 2,804.64M
Operating cash flow 269.37M 273.42M 371.86M 265.60M 363.38M

Valuation Measures

Mar 2020
PER26.38
ROA7.26%
ROE10.75%
Operating margin10.85%
Profit margin8.24%

Key executives

  • President, CEO & Representative Director: Teruhisa Ueda
  • Manager-Finance & Accounting: Shin Bandai
  • Head-Information Systems & Manufacturing: Yasunori Yamamoto
  • Executive Officer: Koyoshi Aoyama
  • Executive Officer & Manager-Legal Affairs: Kenichiro Hirata

Shareholders

  • Meiji Yasuda Life Insurance Co. (7.0%)
  • FIL Investments (Japan) Ltd. (4.0%)
  • Mitsubishi UFJ Financial Group, Inc. (4.0%)
  • MFS International (UK) Ltd. (3.0%)
  • Nomura Asset Management Co., Ltd. (2.7%)
  • The Vanguard Group, Inc. (2.5%)
  • T&D Holdings, Inc. (2.5%)
  • BlackRock Fund Advisors (2.2%)
  • Tokio Marine Holdings, Inc. (2.1%)
  • National Mutual Insurance Fed. of Agricultural Cooperatives (2.0%)

Contact Details

  • Website:http://www.shimadzu.co.jp
  • Address: 1 Nishinokyo Kuwabara-cho, Nakagyo-Ku, Kyoto, 604-8511, Japan
  • Phone: +81.75.823.1111

Related Companies

  • Shimadzu Research Laboratory (Shanghai) Co., Ltd.
  • Shimazu Board Incentive Plan
  • Shimadzu (Guangzhou) Analysis & Technology Services Co. Ltd.
  • Shimadzu Latin America SA
  • Shimadzu Medical Systems (Oceania) Pty Ltd.
  • Shimadzu Korea Vacuum Equipment Co. Ltd.
  • Shimadzu Analytical (India) Pvt Ltd.
  • Shimadzu Scientific Instruments (Taiwan) Co. Ltd.
  • Shimadzu Scientific Instruments (Oceania) Pty Ltd.
  • Shimadzu (China) Co. Ltd.
  • SHIMADZU Philippines Corp.
  • Shimadzu Medical India Pvt. Ltd.
  • Shimadzu do Brasil Comercio Ltda.
  • Shimadzu Research Laboratory (Europe) Ltd.
  • Shimadzu Middle East & Africa FZE
  • Shimadzu South Africa (Pty) Ltd.
  • Shimadzu Taiwan Industrial Machinery Co. Ltd.
  • Shimadzu International Trading (Shanghai) Co. Ltd.
  • Shimadzu Scientific Instruments, Inc. (Pennsylvania)
  • Shimadzu Scientific Instruments, Inc. (Texas)
  • Shimadzu (Hong Kong) Ltd.
  • Medical Imaging Technologies Pty Ltd.
  • Shimadzu Trust
  • Shimadzu Medical Systems USA
  • Shimadzu (Asia Pacific) Pte Ltd.
  • Shimadzu Medical Systems Corp.
  • Shimadzu Device Corp.
  • Shimadzu Precision TechnologyLtd
  • Shimadzu Science East Corp.
  • Shimadzu Logistics Service Corp.

Competitors

  • Agilent Technologies, Inc.
  • Waters Corporation
  • Bruker Corporation
  • Atlas Copco AB Class A
  • II-VI Incorporated
  • Beijing SDL Technology Co., Ltd. Class A
  • MTS Systems Corporation
  • Concentric AB
  • EOS Imaging SA
  • Bio-Techne Corporation
  • Jamco Corporation
  • Vuzix Corporation
Last Updated on 7 Aug, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends July 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media